Korean J Obstet Gynecol.  2007 Sep;50(9):1277-1283.

Malignant gestational trophobalstic tumor with markedly elevated serum hCG levels and negative urine hCG level

Affiliations
  • 1Department of Obstetrics and Gynecology, Seoul Medical Center, Seoul, Korea. sookchomd@hanmail.net

Abstract

Gestational trophoblastic disease comprises a spectrum of interrelated conditions originating from the placenta. Malignant gestational trophoblastic disease refers to lesions that have the potential for local invasion and metastasis. This compromises many histological entities including hydatidiform moles, invasive moles, gestational choriocarcinomas, and placental site trophoblastic tumors. Before the advent of sensitive assays for human chorionic gonadotropin (hCG) and efficacious chemotherapy, the morbidity and mortality from gestational trophoblastic disease were substantial. Currently, with sensitive quantitative assays for beta-hCG and current approaches to chemotherapy, most women with malignant trophoblastic disease can be cured. We present a case of malignant gestational trophobalstic tumor with serum beta-hCG concentration over 1million IU/L that metastaze to the lungs and have a hyperthyroidism, but negative urine hCG testing. We report a case with a brief review of literatures.

Keyword

Urine hCG; Serum beta-hCG; Malignant Gestational trophobalstic tumor

MeSH Terms

Choriocarcinoma
Chorionic Gonadotropin
Drug Therapy
Female
Gestational Trophoblastic Disease
Humans
Hydatidiform Mole, Invasive
Hyperthyroidism
Lung
Mortality
Neoplasm Metastasis
Placenta
Pregnancy
Trophoblastic Tumor, Placental Site
Trophoblasts
Chorionic Gonadotropin
Full Text Links
  • KJOG
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr